Efficacy of pegylated interferon plus ribavirin combination therapy for hepatitis C patients with normal ALT levels: a matched case

Efficacy of pegylated interferon plus ribavirin combination therapy for hepatitis C patients with normal ALT levels: a matched case–control study

Published:2011-08-20 Issue:11 Volume:46 Page:1335-1343
ISSN:0944-1174
Container-title:Journal of Gastroenterology
language:en
Short-container-title:J Gastroenterol

Author:

Hiramatsu Naoki,Inoue Yuko,Oze Tsugiko,Kurashige Nao,Yakushijin Takayuki,Mochizuki Kiyoshi,Miyagi Takuya,Tatsumi Tomohide,Kiso Shinichi,Kanto Tatsuya,Kasahara Akinori,Takehara Tetsuo,Oshita Masahide,Mita Eiji,Hagiwara Hideki,Inui Yoshiaki,Katayama Kazuhiro,Tamura Shinji,Yoshihara Harumasa,Imai Yasuharu,Hayashi Norio

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology

Link

http://link.springer.com/content/pdf/10.1007/s00535-011-0455-1.pdf

Reference24 articles.

1. Martinot-Peignoux M, Boyer N, Cazals-Hatem D, Pham BN, Gervais A, Le Breton V, et al. Prospective study on anti-hepatitis C virus-positive patients with persistently normal serum alanine transaminase with or without detectable serum hepatitis C virus RNA. Hepatology. 2001;34:1000–5.

2. Okanoue T, Makiyama A, Nakayama M, Sumida Y, Mitsuyoshi H, Nakajima T, et al. A follow-up study to determine the value of liver biopsy and need for antiviral therapy for hepatitis C virus carriers with persistently normal serum aminotransferase. J Hepatol. 2005;43:599–605.

3. Persico M, Persico E, Suozzo R, Conte S, De Seta M, Coppola L, et al. Natural history of hepatitis C virus carriers with persistently normal aminotransferase levels. Gastroenterology. 2000;118:760–4.

4. Puoti C, Castellacci R, Montagnese F, Zaltron S, Stornaiuolo G, Bergami N, et al. Histological and virological features and follow-up of hepatitis C virus carriers with normal aminotransferase levels: the Italian prospective study of the asymptomatic C carriers (ISACC). J Hepatol. 2002;37:117–23.

5. Tsuji K, Yamasaki K, Yamanishi M, Kawakami M, Shirahama S. Risk of alanine aminotransferase flare-up among asymptomatic hepatitis C virus RNA carriers: a 10-year follow-up study. J Gastroenterol Hepatol. 2001;16:536–40.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Belgian Randomized Trial in Hepatitis C Virus-Infected Patients with Persistently Normal Alanine Aminotransferase;Global Journal of Clinical Virology;2016-10-15

2. JSH Guidelines for the Management of Hepatitis C Virus Infection: A 2016 update for genotype 1 and 2;Hepatology Research;2016-02

3. Risk factors for hepatocellular carcinoma in hepatitis C patients with normal alanine aminotransferase treated with pegylated interferon and ribavirin;Journal of Viral Hepatitis;2013-08-25

4. Guidelines for the Management of Hepatitis C Virus Infection;Hepatology Research;2013-01

5. Peginterferon alpha-2a and ribavirin in patients with hepatitis C virus genotype 1 infection with persistently normal alanine aminotransferase levels;Journal of Gastroenterology and Hepatology;2012-10-29